308 related articles for article (PubMed ID: 33450835)
1. Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer.
Ali O; Tolaymat M; Hu S; Xie G; Raufman JP
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450835
[TBL] [Abstract][Full Text] [Related]
2. Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.
Felton J; Hu S; Raufman JP
Curr Mol Pharmacol; 2018; 11(3):184-190. PubMed ID: 29357811
[TBL] [Abstract][Full Text] [Related]
3. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells.
Raufman JP; Cheng K; Saxena N; Chahdi A; Belo A; Khurana S; Xie G
Biochem Biophys Res Commun; 2011 Nov; 415(2):319-24. PubMed ID: 22027145
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells.
Xie G; Cheng K; Shant J; Raufman JP
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G755-63. PubMed ID: 19221016
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic muscarinic receptor activation augments murine intestinal epithelial cell proliferation and tumorigenesis.
Peng Z; Heath J; Drachenberg C; Raufman JP; Xie G
BMC Cancer; 2013 Apr; 13():204. PubMed ID: 23617763
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathways of ERK activation by the muscarinic agonists pilocarpine and carbachol in a human salivary cell line.
Lin AL; Zhu B; Zhang W; Dang H; Zhang BX; Katz MS; Yeh CK
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1454-64. PubMed ID: 18385290
[TBL] [Abstract][Full Text] [Related]
8. Blocking Muscarinic Receptor 3 Attenuates Tumor Growth and Decreases Immunosuppressive and Cholinergic Markers in an Orthotopic Mouse Model of Colorectal Cancer.
Kuol N; Davidson M; Karakkat J; Filippone RT; Veale M; Luwor R; Fraser S; Apostolopoulos V; Nurgali K
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614038
[TBL] [Abstract][Full Text] [Related]
9. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules.
Efferth T
Curr Med Chem; 2012; 19(33):5735-44. PubMed ID: 23033949
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor agonists and antagonists: effects on cancer.
Spindel ER
Handb Exp Pharmacol; 2012; (208):451-68. PubMed ID: 22222710
[TBL] [Abstract][Full Text] [Related]
11. R2-8018 reduces the proliferation and migration of non-small cell lung cancer cells by disturbing transactivation between M3R and EGFR.
Lan L; Wang H; Yang R; Liu F; Bi Q; Wang S; Wei X; Yan H; Su R
Life Sci; 2019 Oct; 234():116742. PubMed ID: 31401315
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of M3 muscarinic receptors in progressive colon neoplasia and metastasis.
Cheng K; Shang AC; Drachenberg CB; Zhan M; Raufman JP
Oncotarget; 2017 Mar; 8(13):21106-21114. PubMed ID: 28416748
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic type 3 receptor induces cytoprotective signaling in salivary gland cells through epidermal growth factor receptor transactivation.
Kajiya M; Ichimonji I; Min C; Zhu T; Jin JO; Yu Q; Almazrooa SA; Cha S; Kawai T
Mol Pharmacol; 2012 Jul; 82(1):115-24. PubMed ID: 22511543
[TBL] [Abstract][Full Text] [Related]
14. Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities.
Porru M; Pompili L; Caruso C; Biroccio A; Leonetti C
J Exp Clin Cancer Res; 2018 Mar; 37(1):57. PubMed ID: 29534749
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic Acetylcholine Receptor M3 Expression and Survival in Human Colorectal Carcinoma-An Unexpected Correlation to Guide Future Treatment?
Lobbes LA; Schütze MA; Droeser R; Arndt M; Pozios I; Lauscher JC; Hering NA; Weixler B
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175905
[TBL] [Abstract][Full Text] [Related]
16. Matrix Metalloproteinases: A challenging paradigm of cancer management.
Alaseem A; Alhazzani K; Dondapati P; Alobid S; Bishayee A; Rathinavelu A
Semin Cancer Biol; 2019 Jun; 56():100-115. PubMed ID: 29155240
[TBL] [Abstract][Full Text] [Related]
17. Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR/PI3K/AKT pathway.
Xu R; Shang C; Zhao J; Han Y; Liu J; Chen K; Shi W
Tumour Biol; 2015 Jun; 36(6):4091-100. PubMed ID: 25964092
[TBL] [Abstract][Full Text] [Related]
18. Divergent effects of muscarinic receptor subtype gene ablation on murine colon tumorigenesis reveals association of M3R and zinc finger protein 277 expression in colon neoplasia.
Cheng K; Xie G; Khurana S; Heath J; Drachenberg CB; Timmons J; Shah N; Raufman JP
Mol Cancer; 2014 Apr; 13():77. PubMed ID: 24694019
[TBL] [Abstract][Full Text] [Related]
19. Targeting the EGFR signalling pathway in metastatic colorectal cancer.
Napolitano S; Martini G; Ciardiello D; Del Tufo S; Martinelli E; Troiani T; Ciardiello F
Lancet Gastroenterol Hepatol; 2024 Jul; 9(7):664-676. PubMed ID: 38697174
[TBL] [Abstract][Full Text] [Related]
20. BRET-monitoring of the dynamic changes of inositol lipid pools in living cells reveals a PKC-dependent PtdIns4P increase upon EGF and M3 receptor activation.
Tóth JT; Gulyás G; Tóth DJ; Balla A; Hammond GR; Hunyady L; Balla T; Várnai P
Biochim Biophys Acta; 2016 Mar; 1861(3):177-87. PubMed ID: 26692031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
